News
08-07-2012, 02:14 AM
Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes...
More... (http://www.medicalnewstoday.com/releases/248662.php)
More... (http://www.medicalnewstoday.com/releases/248662.php)